KD Logo

Abbvie Inc [ABBV] stock was sold by GONZALEZ RICHARD A at the price of US$49.5 million

In a filing, Abbvie Inc revealed its EXECUTIVE CHAIRMAN OF BOARD GONZALEZ RICHARD A unloaded Company’s shares for reported $49.5 million on Jul 17 ’24. In the deal valued at $175.00 per share,282,845 shares were sold. As a result of this transaction, GONZALEZ RICHARD A now holds 513,099 shares worth roughly $93.35 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Donoghoe Nicholas sold 21,082 shares, generating $3,716,757 in total proceeds. Upon selling the shares at $176.30, the EVP, CHIEF BUS/STRAT OFFICER now owns 55,903 shares.

Before that, Stewart Jeffrey Ryan sold 58,949 shares. Abbvie Inc shares valued at $10,539,508 were divested by the EVP, CHIEF COMMERCIAL OFFICER at a price of $178.79 per share. As a result of the transaction, Stewart Jeffrey Ryan now holds 60,941 shares, worth roughly $11.09 million.

HSBC Securities upgraded its Abbvie Inc [ABBV] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid May with a ‘”an Overweight”‘ rating. William Blair also remained covering ABBV and has increased its forecast on January 29, 2024 with a “an Outperform” recommendation from previously “Mkt perform” rating. HSBC Securities revised its rating on December 18, 2023. It rated ABBV as “a Hold” which previously was an “a Buy”.

Price Performance Review of ABBV

On Monday, Abbvie Inc [NYSE:ABBV] saw its stock fall -1.74% to $181.94. Over the last five days, the stock has gained 4.80%. Abbvie Inc shares have risen nearly 17.40% since the year began. Nevertheless, the stocks have risen 22.23% over the past one year. While a 52-week high of $186.85 was reached on 07/26/24, a 52-week low of $135.85 was recorded on 05/30/24. SMA at 50 days reached $168.07, while 200 days put it at $162.68. A total of 5.46 million shares were traded, compared to the trading of 6.95 million shares in the previous session.

Levels Of Support And Resistance For ABBV Stock

The 24-hour chart illustrates a support level at 179.60, which if violated will result in even more drops to 177.27. On the upside, there is a resistance level at 185.20. A further resistance level may holdings at 188.47. The Relative Strength Index (RSI) on the 14-day chart is 65.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 9.05, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 23.67%. Stochastics%K at 83.37% indicates the stock is a selling.

Most Popular